Cargando…

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?

Catalyzed by the concerns over the growing public health and economic burden of Hepatitis C virus (HCV) in Switzerland, a diverse group of experts and patient representatives came together in 2014 to develop the Swiss Hepatitis Strategy, setting targets for the elimination of viral hepatitis in Swit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müllhaupt, Beat, Bruggmann, Philip, Bihl, Florian, Blach, Sarah, Lavanchy, Daniel, Razavi, Homie, Robbins Scott, Sarah, Semela, David, Negro, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312389/ https://www.ncbi.nlm.nih.gov/pubmed/30596701 http://dx.doi.org/10.1371/journal.pone.0209374

Ejemplares similares

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
por: Schmidt, Axel J, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
por: Pfeil, Alena M., et al.
Publicado: (2015)

Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
por: Brezzi, Matteo, et al.
Publicado: (2019)

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
por: Busschots, Dana, et al.
Publicado: (2022)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
por: Semmo, Nasser, et al.
Publicado: (2020)

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach
por: Benzaken, Adele Schwartz, et al.
Publicado: (2019)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
por: Popping, Stephanie, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations
por: Bertisch, Barbara, et al.
Publicado: (2016)

“Fighting an uphill battle”: experience with the HCV triple therapy: a qualitative thematic analysis
por: Rasi, Manuela, et al.
Publicado: (2014)

Hepatitis elimination by 2030: Progress and challenges
por: Waheed, Yasir, et al.
Publicado: (2018)

A micro-elimination approach to addressing hepatitis C in Turkey
por: Idilman, Ramazan, et al.
Publicado: (2020)

The impact of immigration on hepatitis B burden in the United States: a modelling study
por: Razavi-Shearer, Devin, et al.
Publicado: (2023)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
por: Grebely, Jason, et al.
Publicado: (2017)

Demonstration of a population-based HCV serosurvey in Ho Chi Minh City, Viet Nam: Establishing baseline prevalence of and continuum of care for HCV micro-elimination by 2030
por: Kim, Thanh V., et al.
Publicado: (2022)

HCV infection prevalence in a population recruited at health centers in Jordan
por: Hamoudi, Waseem, et al.
Publicado: (2013)

Countdown to 2030: eliminating hepatitis B disease, China
por: Liu, Jue, et al.
Publicado: (2019)

Towards the elimination of FGM by 2030: A statistical assessment
por: Weny, Kathrin, et al.
Publicado: (2020)

Towards the elimination of viral hepatitis in Thailand by the year 2030
por: Posuwan, Nawarat, et al.
Publicado: (2020)

Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
por: Mohamed, Rosmawati, et al.
Publicado: (2019)

Eliminating morbidity caused by neglected tropical diseases by 2030
por: Gyorkos, Theresa, et al.
Publicado: (2023)

2030 – Countdown to malaria elimination in India and southeast Asia
por: The Lancet Regional Health – Southeast Asia
Publicado: (2022)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
por: Sarrazin, Christoph, et al.
Publicado: (2021)

Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development
por: Lange, Christian M., et al.
Publicado: (2013)

Rabies Elimination by 2030: What Challenges Does Iran Face?
por: EBRAHIMZADEH LEYLABADLO, Hamed, et al.
Publicado: (2020)

Elimination of hepatitis C in Australia by 2030: a decade and counting
por: Dore, Gregory J
Publicado: (2021)

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
por: About, Frédégonde, et al.
Publicado: (2019)

Modelling NAFLD disease burden in four Asian regions—2019‐2030
por: Estes, Chris, et al.
Publicado: (2020)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

A hundred years of rabies in Kenya and the strategy for eliminating dog-mediated rabies by 2030
por: Bitek, Austine O, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o21ivkt1ft5j6ic3j71lkhmtjc